Poly-Phytopharm Increases Act Score and Serum miR-126 Relative Expressions, and Decreases Blood Eosinophil Levels in Asthma Patients

I Dewa Putu Ardana, Susanthy Djajalaksana, Iin Noor Chozin, Alidha Nur Rakhmani

Abstract


Background: The levels of asthma control is an indicator of asthma management outcomes. A complex immunological mechanism influences it. We aimed to investigate the effect of Poly-Phytopharm on the asthma control tests (ACT) score, blood eosinophil levels, and miR-126 relative expressions in asthma patients.
Methods: Quasi experimental method is used in 15 stable asthma patients who were not fully controlled at the pulmonary outpatient clinic of Dr. Saiful Anwar General Hospital Malang. Assessment of ACT score, blood eosinophil levels, and miR-126 relative expressions are carried out before and after supplementation of Poly-Phytopharm that consist of Nigella sativa 100 mg, Kleinhovia hospita 100 mg, Curcuma xanthorrhiza 75 mg, and Ophiocephalus striatus 100 mg extract, three times a day, two capsules respectively for 12 weeks. The ACT was scored by the investigator by direct questioning of patients, the blood eosinophil level was measured with blood analysis, and the relative expressions of miR-126 was detected with qPCR.
Results: There were significant increase of ACT score (18.07 ± 2.57 to 22.06 ± 1.83, p = 0.001), decrease in blood eosinophil levels (653.15 ± 276.15 pg/mL to 460.66 ± 202.04 pg/mL, p = 0.038), and enhancement of serum miR-126 relative expressions (1.83 ± 1.89 to 5.89 ± 1.34, p = 0.038).
Conclusion: The administration of Poly-Phytopharm increases ACT score, decreases blood eosinophil levels and increases serum miR-126 relative expressions in not fully controlled stable asthma patients.

Keywords


Poly-Phytopharm, Asthma control test, Eosinophil levels, miR-126 relative expressions

References


Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2017; Hal. 14-18.

Ichinose M., Sugiura H., Nagase H. et al. Japanese Guidelines for Adult Asthma 2017. Allergology International. 2017; 66: 163-189.

Primadi O., Sitohang V., Budijanto D. et al. Disease Control and Environmental Health: Chronic and Degeneratif Disease. Indonesian Health Profile. Ch.6. 2014; Hal. 166.

Quirce S., Phillips-Angles E., Dominguez-Ortega J., and Barranco P. Biologics in The Treatment of Severe Asthma. Allergol Immunopathol (Madr). 2017; 45 (S1): 45-49.

Yuliati D., Djajalaksana S., and Rasyid H.A. Efek pemberian Vitamin D pada penderita Asma Bronkial dengan defisiensi Vitamin D terhadap Kadar Interleukin-10, Interleukin-17 dan Skoring ACT. Tugas Akhir Departemen Pulmonologi dan Kedokteran Respirasi FKUB. 2014.

Koshak A., Wei L., Koshak E. et al. Nigella sativa Suplementation Imbproves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial. Phytotherapy Research. 2017; DOI:10.1002/ptr.5761.

Gholamnezhad Z., Keyhanmanesh R., and Boskabady M.H. Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases: A review of basic and clinical evidence. Journal of Functional Foods. 2015; 17: 910–927.

Jia C.E., Zhang H.P., Lv Y. et al. The Asthma Control Test and Asthma Control Questionnaire for assesing asthma control: Systematic review and meta-analysis. J Allergy Clin Immunol. 2013; 131 (3): 695-703.

Tabatabaian F., Ledford D.K., and Casale T.B. Biologic and New Therapies in Asthma. Immunol Allergy Clin N Am. 2017; 37: 329-343.

Amin M., Djajalaksana S., Wiyono W.H. et al. 2018. Pedoman Diagnosis dan Penatalaksanaan Asma Di Indonesia. 1st ed. Chapter 4. Jakarta. Perhimpunan Dokter Paru Indonesia (PDPI). 2018; Hal. 21, 26-29, 45.

Yancey S.W., Keene O.N., Albers F.C. et al. Biomarker for severe eosinophilic asthma. J Allergy Clin Immunol. 2017; 140: 1509-1518.

Svitich O.A., Sobolev V.V., Gankovskaya L.V. et al. The role of regulatory RNAs (miRNAs) in asthma. Allergol Immunopathol (Madr). 2018; DOI: 10.1016/j.aller.2017.09.015.

Fujita Y., Yoshioka Y., Ito S. et al. Intercellular Communication by Extracellular Vesicles and Their MicroRNAs in Asthma. Clin Therapy. 2014; (6): 1-9.

Kalus U., Pruss A., Bystron J. et al. Effect of Nigella sativa (Black Seed) on Subjective Feeling in Patients with Allergic Diseases. Phytotherapy Research. 2003; 17: 1209-1214.

Boskabady M.H., Mohsenpoor N., and Takaloo L. 2010. Antiasthmatic Effect of Nigella sativa in Airway of Asthmatic Patients. Phytomedicine. 17: 707-713.

Nikakhlagh S., Rahim F., Aryani F.H. et al. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaringol. 2011; 32 (5): 402-407.

Ibrahim M., Anwar A., and Yusuf N.I. Uji Lethal Dose 50% Poliherbal pada Heparmin Terhadap Mencit. PT.Royal Medica. 2012.

Ishizaki T., Tamiya T., Taniguchi K. et al. MiR-126 Positively Regulates Mast Cell Proliferation and Cytokine Production Throug Supresing Spred1. Genes to Cells. 2011; 16: 803-814.

Tian M., Ji Y., Wang T. et al. Change in Circulating microRNA-126 Levels are Associated with Immune Imbalance in Children with Acute Asthma. International Journal of Immunopathology and Pharmacology. 2018; 32: 1-7.

Suojalehto H., Toskala E., Kilpelainen M. et al. MicroRNA Profiles in Nasal Mucosa of Patients with Allergic and Nonallergic Rhinitis and Asthma. International Forum of Allergy and Rhinology. 2014; 3 (8): 612-620.




DOI: https://doi.org/10.36497/jri.v39i4.77

Refbacks

  • There are currently no refbacks.





Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter